Guided Therapeutics, Inc.
GTHP
$0.0831
-$0.0059-6.63%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 3.93% | 40.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.35% | 79.45% | |||
| Operating Income | 14.35% | -82.45% | |||
| Income Before Tax | 7.76% | -76.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 7.76% | -76.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.76% | -76.37% | |||
| EBIT | 14.35% | -82.45% | |||
| EBITDA | 14.26% | -82.63% | |||
| EPS Basic | 10.37% | -66.67% | |||
| Normalized Basic EPS | 9.88% | -68.75% | |||
| EPS Diluted | 10.37% | -35.00% | |||
| Normalized Diluted EPS | 9.88% | -68.75% | |||
| Average Basic Shares Outstanding | 1.88% | 2.26% | |||
| Average Diluted Shares Outstanding | 1.88% | 2.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
